Skip to main content

Table 2 Complications and mortality

From: Long-term clinical outcome of patients with severe atherosclerotic renal artery stenosis after percutaneous transluminal renal angioplasty

Observation period, median(IQR)

83(49,106) months

Renal death, n(%)

4(5)

Heart failure, n(%)

17(24)

CCE, n(%)

4(5.4)

Re-PTRA, n(%)

10(14)

Mortality, n(%)

14(19)

Cardiac

6/14(43)

Cancer

5/14(36)

Infection

2/14(14)

Mesenteric infarction

1/14(7)

  1. CCE cholesterol crystal embolism
  2. PTRA percutaneous transluminal renal angioplasty
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us